Assignee
TUBE PHARMACEUTICALS GMBH
AT·2 granted patents·2 pending applications·1 citations·filing 2015–2023
Top patents by PatentIndex Score
4 records- 0171US2024390331A1Oral bendamustine formulationsTUBE PHARMACEUTICALS GMBH·Filed 2023·Application pending·0 cites
- 0266US10183970B2Cytotoxic tubulysin compounds for conjugationTUBE PHARMACEUTICALS GMBH·Filed 2015·Granted Jan 22, 2019·1 cites·9 claims
- 0357US10889616B2Cytotoxic tubulysin compounds for conjugationTUBE PHARMACEUTICALS GMBH·Filed 2018·Granted Jan 12, 2021·0 cites·20 claims
- 0448US2020246312A1Oral bendamustine formulationsTUBE PHARMACEUTICALS GMBH·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when TUBE PHARMACEUTICALS GMBH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →